https://pipelinereview.com/omeros-reports-positive-data-across-primary-and-secondary-endpoints-in-pivotal-trial-of-hematopoietic-stem-cell-transplant-associated-thrombotic-microangiopathy-patients-treated-with-narsoplimab/